Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 10, 2021

View Archived Issues

AFYX Therapeutics presents preclinical data on anti-TNF antibody delivery through adhesive patch

Small-molecule OXS-7417 shows in vivo AML antitumoral effects

StemSynergy Therapeutics patents N-myc proto-oncogene protein inhibitors

Salk Institute, Sanford Burnham Prebys describe new ULK1 inhibitors

New PIKfyve inhibitors identified at AcuraStem

Discovery of novel antibiotic class of tethered macrocyclic peptides

Novel virulence factor LasB inhibitors for the treatment of P. aeruginosa infections

HA-344 shows promise for treating cutaneous metastatic melanoma

PearlRiverBio patents mutant EGFR/HER2 inhibitors

STM-2457: a first-in-class METTL3 inhibitor with preclinical proof of concept in AML models

Flamingo and Ionis expand alliance to develop RNA-targeted therapies for oncology

GRC-39815 shows efficacy in models of smoke-induced COPD

Vitalgenics reports preclinical findings with excindogen in PDAC

Twist collaborates with Boehringer Ingelheim on antibody research programs

KG207-M, a novel bifunctional fusion protein as disease-modifying therapy for AD

Platinum(II)-NHC complex targeting vimentin inhibits tumor metastasis

fMLP receptor promotes inflammatory brain injury

At WCLC, early steps towards success against SCLC

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 8, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...